HomeABNX • EPA
add
Abionyx Pharma SA
Previous close
€1.23
Day range
€1.21 - €1.24
Year range
€0.91 - €1.48
Market cap
42.81M EUR
Avg Volume
65.86K
P/E ratio
-
Dividend yield
-
Primary exchange
EPA
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.26M | -4.20% |
Operating expense | 906.50K | -17.52% |
Net income | -635.00K | 23.31% |
Net profit margin | -50.56 | 19.95% |
Earnings per share | — | — |
EBITDA | -561.50K | 29.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.10M | 1.43% |
Total assets | 14.83M | -6.25% |
Total liabilities | 6.91M | -20.13% |
Total equity | 7.92M | — |
Shares outstanding | 32.21M | — |
Price to book | 4.94 | — |
Return on assets | -9.98% | — |
Return on capital | -13.08% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -635.00K | 23.31% |
Cash from operations | -579.50K | -116,000.00% |
Cash from investing | -29.50K | -1,280.00% |
Cash from financing | 1.70M | 84,900.00% |
Net change in cash | 1.09M | 108,600.00% |
Free cash flow | -290.00K | 40.54% |
About
Founded
2005
Website
Employees
61